Creative Planning’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Creative Planning’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-107,662	Closed	-$1.2M	–	2828
2022 Q4	$1.2M	Buy	107,662 +1,000	+0.9%	+$9.69K	﹤0.01%	951
2022 Q3	$599K	Hold	106,662	–	–	﹤0.01%	1218
2022 Q2	$462K	Hold	106,662	–	–	﹤0.01%	1365
2022 Q1	$1.24M	Buy	106,662 +6,633	+7%	+$79K	﹤0.01%	889
2021 Q4	$1.83M	Buy	100,029 +30,956	+45%	+$393K	﹤0.01%	713
2021 Q3	$819K	Hold	69,073	–	–	﹤0.01%	1045
2021 Q2	$1.19M	Hold	69,073	–	–	﹤0.01%	870
2021 Q1	$1.26M	Hold	69,073	–	–	﹤0.01%	916
2020 Q4	$1.3M	Buy	+69,073	New	+$1.49M	﹤0.01%	836

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Creative Planning's OYST Position: Q1 2023 in Review

Creative Planning sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 107,662 shares — an estimated $1.2M sold.

Creative Planning first reported a position in OYST in Q4 2020 and held it in 9 quarters. The position peaked at $1.83M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Creative Planning reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Creative Planning sold 107,662 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.2M.
Creative Planning first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Creative Planning's Oyster Point Pharma, Inc. Common Stock position peaked at $1.83M in Q4 2021.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Creative Planning's 13F filing for Q1 2023, filed 15 May 2023.